Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab
in patients with squamous lung cancer. Though it achieved a
statistical increase in OS, he does not consider it clinically
About the Podcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.